Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high14.4000 06/03/17
52 week low7.0000 03/02/17
52 week change 1.5560 (19.76%)
4 week volume15,044,122 28/06/17

Media for (NIPT)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 4052L Premaitha Health PLC 18 July 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Premaitha Health ...

Premaitha Health extends Thermo Fisher Scientific agreement

Premaitha Health has entered into a further extension of the investment agreement with Thermo Fisher Scientific, the latt...

Investment Agreement Extension with Thermo Fisher

RNS Number: 7829K Premaitha Health PLC 12 July 2017 Premaitha Health Plc ("Premaitha", the "Company" or the "Group") Investment Agreement Extension with Thermo Fisher Scientific Manchester, UK - 12 July 2017 - Premaitha Health Plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing , is pleased to an...

Premaitha announces two laboratory hub contracts

Premaitha Health has signed contracts with two significant laboratories in South East Asia through its Taiwanese subsidiar...

Premaitha announces two laboratory hub contracts

RNS Number: 5206K Premaitha Health PLC 10 July 2017 Premaitha Health plc ("Premaitha" or the "Company" or the "Group") Premaitha announces two laboratory hub contracts in South East Asia Manchester, UK - 10 July 2017: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT...

Litigation Update

RNS Number: 8084J Premaitha Health PLC 03 July 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Litigation Update Manchester, UK - 3 July 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), provides the following update on the legal proceedings in con...

Holding(s) in Company

RNS Number: 2141J Premaitha Health PLC 27 June 2017 TR-1: notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Premaitha Health PLC 2. Reason for the notification(please tick the appropriate box or boxes) An acquisition or disposal of voting rights An acquisition or disposal o...

Premaitha launches Sage NIPT solution in Hong Kong

Premaitha Health announces the launch of Sage, a non-invasive prenatal testing (NIPT) solution incorporating additional p...

Fundamental DataMore

EPS-6
Dividend yield0 %

Equity Research (NIPT)

hardman & co
Premaitha Health PLC
17/03/2017
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is carrying...
hardman & co
Premaitha Health PLC
11/01/2017
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is carrying...
hardman & co
Premaitha Health PLC
20/04/2016
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA® uses complex statistical analysis to determine the likelihood that a fetus is carrying...

Latest discussion posts More

  • Thermo Fisher Support.

    The support and investment keeps coming for NIPT. Get this litigation out of the way and it will be clear blue skies.. Eventually Premaitha will become a takeover tarhet, ...
    12-Jul-2017
    Disorder
  • Re: share price in august?

    I know that Premaitha are intending to cite the recent German instances as set precendences within the defence of the Illuminia patent infringment claims. What with the sp ...
    10-Jul-2017
    Disorder
  • 2 New Labs (Asia)

    Well done NIPT. Great to see the continued diversification across Asia, which as we all know is outside the remit of the patent infringment claims. :-) Premaitha Health ...
    10-Jul-2017
    Disorder

Users' HoldingsMore

Users who hold Premaitha Health also hold..
LLOYDS GRP.19%
ROCKHOPPER18%
GULF KEYSTONE15%
RANGE RES.12%
ID:ISIN:VGG9828A119411%

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT